文献速递产科母胎医学

晚发型胎儿生长受限的管理:实用方法

Management of late-onset fetal growth restriction: pragmatic approach.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-01-01

前瞻性研究纳入321例≥32周疑似晚发型胎儿生长受限孕妇,按超声标准分为低危组和高危组分别管理。低危组不良新生儿结局显著低于高危组(45% vs 58%;aOR 0.6,95%CI 0.4-0.9;P=0.022)。低危组不良新生儿结局也低于历史队列中回顾性判定的低危组(45% vs 58%;aOR 0.6,95%CI 0.4-0.9;P=0.026)。作者认为风险分层管理可减少低危妊娠的不良新生儿结局,但需随机对照试验评估。

要点

  • 晚发型FGR按超声标准分为低危和高危组管理,低危组不良新生儿结局显著低于高危组。
  • 低危组与历史队列回顾性低危组相比,不良新生儿结局显著降低。
  • 严重不良新生儿结局和不良母体结局在两组间无显著差异。

核心结论

  • 适当的风险分层管理晚发型FGR与低危妊娠不良新生儿结局发生率降低相关。
  • 作者认为,临床实践中对足月低危晚发型FGR孕妇采取期待管理策略可能改善新生儿和远期发育。
  • 需要随机对照试验评估基于证据的晚发型FGR保守管理方案对围产期发病和死亡及远期神经发育的影响。

研究设计与样本

  • 前瞻性研究,纳入2018年2月至2019年9月伦敦一家三级医院≥32周单胎非畸形妊娠孕妇321例。
  • 低危组156例,高危组165例;并与新方案实施前管理的323例历史队列比较。
  • 主要结局为不良新生儿结局,次要结局为不良母体结局和严重不良新生儿结局。

主要发现

  • 低危组与高危组不良新生儿结局:45% vs 58%(aOR 0.6,95%CI 0.4-0.9;P=0.022),低危组显著更低。
  • 低危组与高危组不良母体结局:18% vs 24%(aOR 0.7,95%CI 0.4-1.2;P=0.142),无显著差异。
  • 低危组与高危组严重不良新生儿结局:3.8% vs 8.5%(aOR 0.5,95%CI 0.2-1.3;P=0.153),无显著差异。
  • 新方案低危组与历史队列回顾性低危组不良新生儿结局:45% vs 58%(aOR 0.6,95%CI 0.4-0.9;P=0.026),新方案组显著更低。

关键数值与推荐

  • 纳入标准:估计胎儿体重(EFW)≤第10百分位,或EFW>第10百分位且腹围较前次扫描下降≥50百分位、脐动脉多普勒搏动指数>第95百分位或脑胎盘比<第5百分位。
  • 高危组标准:EFW<第3百分位、脐动脉多普勒搏动指数>第95百分位,或EFW在第3至第10百分位(含)且腹围下降或Doppler异常;于37周或稍后分娩。
  • 低危组于41周前分娩,除非后续符合高危标准。

临床怎么用

  • 作者认为,临床实践中对足月低危晚发型FGR孕妇采取期待管理策略可能改善新生儿和远期发育。
  • 作者提出需要随机对照试验评估基于证据的晚发型FGR保守管理方案对围产期发病和死亡及远期神经发育的影响。

局限性

  • 需要随机对照试验评估基于证据的晚发型FGR保守管理方案对围产期发病和死亡及远期神经发育的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: There is limited prospective evidence to guide the management of late-onset fetal growth restriction (FGR) and its differentiation from small-for-gestational age. The aim of this study was to assess prospectively a novel protocol in which ultrasound criteria were used to classify women with suspected late FGR into two groups: those at low risk, who were managed expectantly until the anticipated date of delivery, and those at high risk, who were delivered soon after 37 weeks of gestation. We also compared the outcome of this prospective cohort with that of a historical cohort of women presenting similarly with suspected late FGR, in order to evaluate the impact of the new protocol. METHODS: This was a prospective study of women with a non-anomalous singleton pregnancy at ≥ 32 weeks' gestation attending a tertiary hospital in London, UK, between February 2018 and September 2019, with estimated fetal weight (EFW) ≤ 10th centile, or EFW > 10th centile in addition to a decrease in fetal abdominal circumference of ≥ 50 centiles compared with a previous scan, umbilical artery Doppler pulsatility index > 95th centile or cerebroplacental ratio < 5th centile. Women were classified as low or high risk based on ultrasound and Doppler criteria. Women in the low-risk group were delivered by 41 weeks of gestation, unless they subsequently met high-risk criteria, whereas women in the high-risk group (EFW < 3rd centile, umbilical artery Doppler pulsatility index > 95th centile or EFW between 3rd and 10th centiles (inclusive) with abdominal circumference drop or abnormal Dopplers) were delivered at or soon after 37 weeks. The primary outcome was adverse neonatal outcome and included hypothermia, hypoglycemia, neonatal unit admission, jaundice requiring treatment, suspected infection, feeding difficulties, 1-min Apgar score < 7, hospital readmission and any severe adverse neonatal outcome (perinatal death, resuscitation using inotropes or mechanical ventilation, 5-min Apgar score < 7, metabolic acidosis, sepsis, and cerebral, cardiac or respiratory morbidity). Secondary outcomes were adverse maternal outcome (operative delivery for abnormal fetal heart rate) and severe adverse neonatal outcome. Women managed according to the new protocol were compared with a historical cohort of 323 women delivered prior to the implementation of the new protocol, for whom management was guided by individual clinician expertise. RESULTS: Over 18 months, 321 women were recruited to the prospective cohort, of whom 156 were classified as low risk and 165 were high risk. Adverse neonatal outcome was significantly less common in the low-risk compared with the high-risk group (45% vs 58%; adjusted odds ratio (aOR), 0.6 (95% CI, 0.4-0.9); P = 0.022). There was no significant difference in the rate of adverse maternal outcome (18% vs 24%; aOR, 0.7 (95% CI, 0.4-1.2); P = 0.142) or severe adverse neonatal outcome (3.8% vs 8.5%; aOR, 0.5 (95% CI, 0.2-1.3); P = 0.153) between the low- and high-risk groups. Compared with women in the historical cohort classified retrospectively as low risk, low-risk women managed under the new protocol had a lower rate of adverse neonatal outcome (45% vs 58%; aOR, 0.6 (95% CI, 0.4-0.9); P = 0.026). CONCLUSIONS: Appropriate risk stratification to guide management of late FGR was associated with a reduced rate of adverse neonatal outcome in low-risk pregnancies. In clinical practice, a policy of expectantly managing women with a low-risk late-onset FGR pregnancy at term could improve neonatal and long-term development. Randomized controlled trials are needed to assess the effect of an evidence-based conservative management protocol for late FGR on perinatal morbidity and mortality and long-term neurodevelopment. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Peasley R, Rangel LAA, Casagrandi D, et al. Management of late-onset fetal growth restriction: pragmatic approach. Ultrasound Obstet Gynecol. 2023. PMID: 36864542. doi:10.1002/uog.26190

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。